According to Bernstein's analysis, although BASF previously abandoned its acquisition of Evonik, shareholders of Evonik may push management back to the negotiating table amid the decline in Evonik's share price and the possibility of a higher potential bid. A merger and acquisition deal between BASF and Evonik could still move forward at a higher price. Currently, Evonik's shares are down 17% at €18.17, while BASF shares are down 0.3% at €51.03.